Peninsula drug maker's Son of Yervoy dares cancer to pull off its mask
Bristol-Myers Squibb's Yervoy was a cutting-edge cancer immunotheapy. Now it's teamed with a South San Francisco company to take a new version of the drug, potentially with fewer side effects, into clinical trials.
Source: bizjournals.com Health Care:Physician Practices headlines - Category: American Health Authors: Ron Leuty Source Type: news
More News: American Health | Cancer | Cancer & Oncology | Clinical Trials | Health Management | Yervoy